Clinical anti-lymphoma activity and toxicity of T cells expressing a novel anti-CD19 chimeric antigen receptor with fully-human variable regions.

被引：5

作者：

Brudno, Jennifer N.

Hartman, Steven D.

Pittaluga, Stefania

Stroncek, David

Lam, Norris

Kanakry, Jennifer Ann

Pavletic, Steven Zivko

Mikkilineni, Lekha

Bagheri, Mohammadhadi

Roschewski, Mark J.

Dean, Robert M.

Rose, Jeremy J.

Patel, Rashmika

Hansen, Brenna G.

Gress, Ronald

Kochenderfer, James

机构：

[1] Natl Canc Inst, Expt Transplantat & Immunol Branch, Bethesda, MD USA

[2] Natl Canc Inst, Ctr Canc Res, Bethesda, MD USA

[3] Natl Inst Hlth, Dept Transfus Med, Clin Ctr, Bethesda, MD USA

[4] Natl Inst Hlth, Dept Radiol & Imaging Sci, Clin Ctr, Bethesda, MD USA

[5] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA

[6] Case Comprehens Canc Ctr, Cleveland, OH USA

来源：

关键词：

D O I：

10.1200/JCO.2018.36.15_suppl.3052

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

3052

引用

页数：1